J&J Stresses Data Comparison In Push For Top Interventional Cardiology Spot

Price premiums and increased procedures related to drug-coated stents are expected to more than double the worldwide interventional cardiology market to $9.2 bil. over the next six years, Johnson & Johnson/Cordis predicts.